<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | Bryan Xavier | Activity</title>
	<link>https://medicaldevicecourses.com/members/bryan-xavier/activity/</link>
	<atom:link href="https://medicaldevicecourses.com/members/bryan-xavier/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bryan Xavier.</description>
	<lastBuildDate>Sat, 25 Apr 2026 00:17:23 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ca28a05f61a05da8a94dbe5efd946ef2</guid>
				<title>Bryan Xavier replied to the topic  &#034;Ghantt Chart vs. Network Diagram vs. Other?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33742/</link>
				<pubDate>Mon, 17 Nov 2025 18:48:13 -0500</pubDate>

									<content:encoded><![CDATA[<p>Many times in the weekly lesson, we learn about two ways to run a part of a company or project, and we often learn that most versatile is a balance between the two. I think this is also similar to&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/organizational-development-in-device-companies/ghantt-chart-vs-network-diagram-vs-other/#post-22785" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">38e6fa69c83480da603ac9f6badb1485</guid>
				<title>Bryan Xavier replied to the topic  &#034;Matrix Strength&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33741/</link>
				<pubDate>Mon, 17 Nov 2025 18:09:30 -0500</pubDate>

									<content:encoded><![CDATA[<p>Besides the type of project determining what type of matrix is used, another factor that should determine the matrix used is the amount of risk the produce has if it fails. Any device that is life-supporting have very high patient&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/organizational-development-in-device-companies/matrix-strength/#post-22784" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">30f1e782d594d8b256646ed590ee3d0f</guid>
				<title>Bryan Xavier replied to the topic  &#034;Value-based healthcare: &#034;Dos and Don&#039;ts&#034;&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33740/</link>
				<pubDate>Mon, 17 Nov 2025 17:18:03 -0500</pubDate>

									<content:encoded><![CDATA[<p>To meet the value-based care expectations, medical device companies could also focus on creating internal teams that focus on making their medical devices more accessible across more places. This could mean making devices easier to use or to be trained&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/organizational-development-in-device-companies/value-based-healthcare-dos-and-donts/#post-22783" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0a02047366c8c9d95253d0d2920f94e2</guid>
				<title>Bryan Xavier replied to the topic  &#034;Risk Management in the Manufacturing Process&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33619/</link>
				<pubDate>Tue, 11 Nov 2025 04:46:57 -0500</pubDate>

									<content:encoded><![CDATA[<p>I think documentation of each potential risk found and measures to deal with it, whether it be avoidance or mitigation. It&#8217;s important that if a risk it found, there&#8217;s no way for it to appear frequently once the product reaches&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/risk-analysis-for-medical-devices/risk-management-in-the-manufacturing-process/#post-22692" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">206f5f4d163f256c573a907f6690a3b7</guid>
				<title>Bryan Xavier replied to the topic  &#034;Distinguishing Between Hazards and Hazardous Situations in Risk Evaluation&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33618/</link>
				<pubDate>Tue, 11 Nov 2025 04:20:11 -0500</pubDate>

									<content:encoded><![CDATA[<p>I think the distinction is important because they happen at different stages, and thus must be managed differently. Hazards are managed by prevention to stop the danger from ever happening in the first place. That&#8217;s why regular maintenance is usually&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/risk-analysis-for-medical-devices/distinguishing-between-hazards-and-hazardous-situations-in-risk-evaluation/#post-22691" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ccd0f30f4ef2c5f79ce089af9ff3448a</guid>
				<title>Bryan Xavier replied to the topic  &#034;Residual risk during device development&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33608/</link>
				<pubDate>Mon, 10 Nov 2025 19:51:25 -0500</pubDate>

									<content:encoded><![CDATA[<p>I think a good way to decided what levels of residual risk is acceptable is to create a quantifiable way to measure it, instead of leaving it up to opinions. The scale would make it clearer for how often the&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/risk-analysis-for-medical-devices/residual-risk-during-device-development/#post-22681" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">84a3bf8489d4bb985da88d988e512e3d</guid>
				<title>Bryan Xavier replied to the topic  &#034;When Design Controls Fail — The DePuy Hip Recall&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33566/</link>
				<pubDate>Sun, 09 Nov 2025 20:23:19 -0500</pubDate>

									<content:encoded><![CDATA[<p>The failure of the DePuy hip implant is probably due to not enough diversity in the testing population. Real world patients can vary widely in weight, height bone density and levels of physical activity can affect an implant&#8217;s effectiveness over&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/when-design-controls-fail-the-depuy-hip-recall/#post-22639" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7f5612c31814e219087b4e8064e0333d</guid>
				<title>Bryan Xavier replied to the topic  &#034;Process Validation for OEMs&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33561/</link>
				<pubDate>Sun, 09 Nov 2025 18:51:03 -0500</pubDate>

									<content:encoded><![CDATA[<p>A good CM manufacturer should validate machines and have a maintenance plan, and also provide full documentation for proof that the process works the same way every time. The document should have test plans, results and checks if the equipment&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/process-validation-for-oems/#post-22634" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">41e2fb176adfda27114406e91f447406</guid>
				<title>Bryan Xavier replied to the topic  &#034;How Many Design Reviews Are Enough?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33560/</link>
				<pubDate>Sun, 09 Nov 2025 18:29:39 -0500</pubDate>

									<content:encoded><![CDATA[<p>I agree that multiple review meeting should be made during a medical device&#8217;s lifecycle. Deciding on how many meetings are happening should be governed by what goals must be met before being able to move on to the next step&#8230;. &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/how-many-design-reviews-are-enough/#post-22633" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b02057acd586163af7a3978250c8955b</guid>
				<title>Bryan Xavier replied to the topic  &#034;The Relationship Between Verification and Validation&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33388/</link>
				<pubDate>Fri, 31 Oct 2025 12:43:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>I would probably say that this is more a case by case approach. For devices or features that are high risk, verifications and validation should be strictly separate to keep results trustworthy. But for lower risk features, you can afford&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/the-relationship-between-verification-and-validation/#post-22513" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">bda1487a277dec08b8d4cf3763c21ddd</guid>
				<title>Bryan Xavier replied to the topic  &#034;Details needed in a DHF for complex devices&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33386/</link>
				<pubDate>Fri, 31 Oct 2025 03:55:53 -0400</pubDate>

									<content:encoded><![CDATA[<p>How about instead you design the DHF around making it easier for the reviewer to read it in mind, rather than the regular documents? Starting with a one-page index of the most critical user needs and for each one, creating&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/details-needed-in-a-dhf-for-complex-devices/#post-22511" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">020ef02359c2509c95e198bc29daedae</guid>
				<title>Bryan Xavier replied to the topic  &#034;Do Design Controls Help Innovation or Slow It Down?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33385/</link>
				<pubDate>Fri, 31 Oct 2025 03:35:38 -0400</pubDate>

									<content:encoded><![CDATA[<p>Design control can actually be better for innovation, as it acts as a filter that would let ideas that wouldn&#8217;t pass regulation be rejected immediately, and the constraints would force for more unique innovations that still manage to be within&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-design-controls/do-design-controls-help-innovation-or-slow-it-down/#post-22510" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8d1caf38468aaaea201c2f0a6685254a</guid>
				<title>Bryan Xavier replied to the topic  &#034;Patient safety and data integrity during clinical trials&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33318/</link>
				<pubDate>Sun, 26 Oct 2025 17:36:33 -0400</pubDate>

									<content:encoded><![CDATA[<p>An important guideline for medical companies is ensuring data integrity in clinical research. This is where the ALCOA+ principle (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available) comes in, and what CRAs look for regarding documents and&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/clinical-research-basics/patient-safety-and-data-integrity-during-clinical-trials/#post-22455" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2366a1d00210f1bb0c781ece2b630766</guid>
				<title>Bryan Xavier replied to the topic  &#034;Biomedical Engineers role in Clinical Research&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33317/</link>
				<pubDate>Sun, 26 Oct 2025 17:00:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>Along with everything else, everyone has mentioned, biomedical engineers also help with making sure that what a clinical trial measures actually matters. The study has to show specific results that show whether a device worked or not. Engineers help translate&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/clinical-research-basics/biomedical-engineers-role-in-clinical-research/#post-22454" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b576232d9aeff026e65d35cca190bdfa</guid>
				<title>Bryan Xavier replied to the topic  &#034;Gold Standard or Paperwork Nightmare?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33316/</link>
				<pubDate>Sun, 26 Oct 2025 12:24:00 -0400</pubDate>

									<content:encoded><![CDATA[<p>While GCP regulations can slow development, the FDA has several programs in place that see to expedite the wait time. In class when learning about the specific pathways that medical products can take, we also learned about Investigational Device Exemption&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/clinical-research-basics/gold-standard-or-paperwork-nightmare/#post-22453" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1fe0a52e6dfdf0c9135d9cb7c2764f79</guid>
				<title>Bryan Xavier replied to the topic  &#034;Consumer Input for Marketing Outputs&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33207/</link>
				<pubDate>Sun, 19 Oct 2025 12:49:12 -0400</pubDate>

									<content:encoded><![CDATA[<p>You can make medical device marketing more ethical and accurate by doing a human-factors testing, something similar to testing that&#8217;s done during device design. Before releasing ads about the product to the public, companies could first show them to a&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/consumer-input-in-marketing-outputs/#post-22376" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">adff5c7326832d757eec485a43d0c52e</guid>
				<title>Bryan Xavier replied to the topic  &#034;Medical Device Marketing: Informative or Misleading?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33206/</link>
				<pubDate>Sun, 19 Oct 2025 12:27:25 -0400</pubDate>

									<content:encoded><![CDATA[<p>I think one way to keep medical device marketing effective while still being ethical is implementing something similar to a traceability matrix into the marketing process. This would require every statement used in marketing to be required to be connected&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/medical-device-marketing-informative-or-misleading/#post-22375" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">28e2c63db097a955108253c9113790f2</guid>
				<title>Bryan Xavier replied to the topic  &#034;Marketing Strategies to Differentiate from the Competition&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/33205/</link>
				<pubDate>Sun, 19 Oct 2025 11:59:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>For marketing products in general, knowing who your audience is can determine how to optimize your marketing strategy towards that audience. For medical devices specifically, that audience would typically be the hospital&#8217;s internal evaluation group rather than just physicians. Most&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/marketing-strategies-to-differentiate-from-the-competition/#post-22374" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2a743f35eb61831d0ee556bb6762864f</guid>
				<title>Bryan Xavier replied to the topic  &#034;Starting a Business as a Physician&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32936/</link>
				<pubDate>Thu, 09 Oct 2025 03:26:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>Physicians branching out into entrepreneurship can have positive effects on healthcare. However, access can also be an issue with newly developed technologies. Not every community will equally benefit from those innovations. Telehealth, for example, requires that patients have reliable access&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/business-101/starting-a-business-as-a-physician/#post-22244" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b69bc0e6853b0d669d451127e41394e3</guid>
				<title>Bryan Xavier replied to the topic  &#034;The Corporate Veil&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32897/</link>
				<pubDate>Wed, 08 Oct 2025 04:07:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>I think that the corporate veil is an important protection that allows people to take on the risk of starting a company or investing in one in the first place. Without that protection, the uncertainty of a business surviving or&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/business-101/the-corporate-veil/#post-22226" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a9f33f6671fc1e778606d03a6ccde006</guid>
				<title>Bryan Xavier posted a new topic  &#034;Public vs. Private&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32844/</link>
				<pubDate>Tue, 07 Oct 2025 04:25:53 -0400</pubDate>

									<content:encoded><![CDATA[<p>Recently, Electronic Arts (EA), a once publicly traded company, agreed to a deal that will make it go private Once this transition happens, EA will no longer have to publish quarterly earnings that allow shareholders to decide whether they want&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/business-101/public-vs-private/" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c61862ee8b0a4e0ef61510aea466bc0d</guid>
				<title>Bryan Xavier replied to the topic  &#034;Audit Culture&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32782/</link>
				<pubDate>Mon, 06 Oct 2025 03:01:41 -0400</pubDate>

									<content:encoded><![CDATA[<p>Obviously, AI is already being heavily researched and expanded on, with many companies finding way on how to seamlessly implement it into their system. AI can indeed help handle routine pats, like checking if training is up-to-date, finding documents or&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/quality-control-and-quality-assurance/audit-culture/#post-22188" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">41bfb7efa0e9ed7a7042dede6550fd82</guid>
				<title>Bryan Xavier replied to the topic  &#034;Quality Control &#038; Quality Assurance Communication&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32779/</link>
				<pubDate>Mon, 06 Oct 2025 02:53:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>It&#8217;s true that having things be more measurable makes it easier to provide clear results. One way I see of preventing that can be to create a checklist between QA and QC that explains what standards QA expects, and QC&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/quality-control-and-quality-assurance/quality-control-quality-assurance-communication/#post-22185" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2401c01eb26e0131c17975316e6de162</guid>
				<title>Bryan Xavier replied to the topic  &#034;Unified Quality System?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32777/</link>
				<pubDate>Mon, 06 Oct 2025 02:49:43 -0400</pubDate>

									<content:encoded><![CDATA[<p>While creating one unified quality system sound more efficient, it can actually create more problems when companies work in different regions. Depending on the countries, their rules can be different, like different reporting timelines. If a company forces all other&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/quality-control-and-quality-assurance/unified-quality-system/#post-22183" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6cf085c5e3d60844006a5417b23dae66</guid>
				<title>Bryan Xavier replied to the topic  &#034;Balancing Innovation and Safety&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32452/</link>
				<pubDate>Sun, 28 Sep 2025 03:47:23 -0400</pubDate>

									<content:encoded><![CDATA[<p>The FDA&#8217;s Breakthrough Devices and Safer Technologies (STeP) programs are designed to speed up innovation for unmet medical needs. It gives manufacturers earlier and more frequent interactions with reviewers and review timelines, helping unique promising technologies reach patients that need&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/regulatory-basics-for-medical-devices/balancing-innovation-and-safety/#post-22064" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7fcf6a5e2de036f4e38284ba3e59daca</guid>
				<title>Bryan Xavier replied to the topic  &#034;FDA Classes: Reform needed or fine as is?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32450/</link>
				<pubDate>Sun, 28 Sep 2025 02:38:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>The FDA&#8217;s classification framework works well for physical devices because risk is tied to how much contact the patient makes with the device. Software wouldn&#8217;t exactly work with that classification, due to the danger coming from inaccurate readings rather than&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/regulatory-basics-for-medical-devices/fda-classes-reform-needed-or-fine-as-is/#post-22062" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4e1ab2a00b39aa4c914f554d28f7ee61</guid>
				<title>Bryan Xavier replied to the topic  &#034;Should Engineers Worry About Compliance From the Start?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32449/</link>
				<pubDate>Sun, 28 Sep 2025 01:46:17 -0400</pubDate>

									<content:encoded><![CDATA[<p>I think the classification that the project will be in can also affect how early or late creative freedom should be considered. Since different classes will have pathways with varying qualifications they need to follow, the classes that require fewer&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/regulatory-basics-for-medical-devices/should-engineers-worry-about-compliance-from-the-start/#post-22061" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3d417cbf530ae8a9de66c218fcade3f6</guid>
				<title>Bryan Xavier replied to the topic  &#034;Ensuring Biocompatibility in Medical Devices&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32136/</link>
				<pubDate>Sat, 20 Sep 2025 10:44:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>Testing biocompatibility during the designing process is important, but biocompatible for the device has to be managed across its entire lifecycle. If a new method is used when making a product, like a different supplier, reassuring biocompatibility after is a&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/pre-clinical-device-development/ensuring-biocompatibility-in-medical-devices/#post-21953" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">bd16d8831fbaf0fadb916aa8e282b38b</guid>
				<title>Bryan Xavier replied to the topic  &#034;Key factors to consider while selecting appropriate animal models for pre-clinical research to develop therapies for neurological disorders.&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32135/</link>
				<pubDate>Sat, 20 Sep 2025 10:26:09 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/krish/' rel="nofollow ugc">@krish</a> I definitely agree with you that organ on a chip model are slowly reducing our dependence on animal studies. The FDA themselves have also pushed for this, as the FDA Modernization Act 2.0 allows for organ on a chip&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/pre-clinical-device-development/key-factors-to-consider-while-selecting-appropriate-animal-models-for-pre-clinical-research-to-develop-therapies-for-neurological-disorders/#post-21952" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">59cd6d2a466672ca9cb71d3b01d113a8</guid>
				<title>Bryan Xavier replied to the topic  &#034;Pitching Research in Industry vs. Academia&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/32132/</link>
				<pubDate>Sat, 20 Sep 2025 09:44:50 -0400</pubDate>

									<content:encoded><![CDATA[<p>I have just started working in the biopharmaceutical industry, and one of the things they really hammer down is following protocol in order to stay within federal regulations. If we slip out of compliance, production can be stalled or even&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/pre-clinical-device-development/pitching-research-in-industry-vs-academia/#post-21951" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">36aef3d7d1683f396770c1dfe57582c0</guid>
				<title>Bryan Xavier replied to the topic  &#034;Scope Management: Balancing Innovation and Constraints&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31838/</link>
				<pubDate>Thu, 11 Sep 2025 01:33:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>It&#8217;s fine to consider some innovation, as long you can differentiate something the project truly needs and is worth the potential extra time and resources to enact this change. In my experience working on a product, we make a list&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/intro-to-project-management/scope-management-balancing-innovation-and-constraints/#post-21830" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4a967bc3ff54f376a710ff988c8dada8</guid>
				<title>Bryan Xavier replied to the topic  &#034;When Does It Makes Sense To Give Up On A Project?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31837/</link>
				<pubDate>Thu, 11 Sep 2025 00:54:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>I agree with having feasibility check at the initiation phase of the project. However, to add to that, maybe it would be good practice to hold a risk assessment meeting and come up with a certain condition where it becomes clear&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/intro-to-project-management/when-does-it-makes-sense-to-give-up-on-a-project/#post-21829" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">e64d743bf21693537053470f2e61c811</guid>
				<title>Bryan Xavier replied to the topic  &#034;Managing Team Opinions While Sticking to Decisions&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31836/</link>
				<pubDate>Thu, 11 Sep 2025 00:04:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>Depending on the severity of the disagreement, it can be helpful to the team if you also bring an outside perspective, specifically someone who has faced an issue similar to the one causing the disagreement. This way, it feels less&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/intro-to-project-management/managing-team-opinions-while-sticking-to-decisions/#post-21828" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2af2b07c2c5857c4bc288160eb8d64c9</guid>
				<title>Bryan Xavier replied to the topic  &#034;Thoughts on BME degree, &#034;a little of everything&#034;&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31722/</link>
				<pubDate>Thu, 04 Sep 2025 21:12:50 -0400</pubDate>

									<content:encoded><![CDATA[<p>I actually see the jack of all trades aspect of BME having some positive outcomes in my own experience. For me specifically, I wanted to focus on data analysis focus jobs, but because I also had experience working in biolabs&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-medical-device-development/thoughts-on-bme-degree-a-little-of-everything/paged/5/#post-21734" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">83fdc4ca9dfb63ec548cf6794716c6dc</guid>
				<title>Bryan Xavier replied to the topic  &#034;Experience vs Education&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31721/</link>
				<pubDate>Thu, 04 Sep 2025 20:35:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>I&#8217;d lean more toward more co-ops or longer internships, due to the multiple years of experience employer often expect for a lot of jobs. For students, co-op can give the student the required experience while being able to juggle both&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-medical-device-development/experience-vs-education/#post-21733" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">99e80f3735585d75c72472b4e5ff5883</guid>
				<title>Bryan Xavier replied to the topic  &#034;Academia vs. Industry: Why I Prefer Industry&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31718/</link>
				<pubDate>Thu, 04 Sep 2025 20:04:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>I also see myself drawn to industry. For me, it&#8217;s mostly because I feel more comfortable dealing with a defined problem with a set deadline rather than the more open-ended approach. I&#8217;ve noticed that tangible progress motivates me more, and&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-medical-device-development/academia-vs-industry-why-i-prefer-industry/#post-21732" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">86d04d71aba18c8d73c279e4420f14b1</guid>
				<title>Bryan Xavier replied to the topic  &#034;Early Risk Management in a Project&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31473/</link>
				<pubDate>Wed, 30 Apr 2025 04:17:55 -0400</pubDate>

									<content:encoded><![CDATA[<p>To make the team aware of risk on even smaller, simpler projects, you could incorporate short &#8220;Risk Sprints&#8221; in regular intervals of the planning cycle. In each of these meetings, the team will look for new risks that can possible&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/early-risk-management-in-a-project/#post-21620" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">28bbf79ef21f1b9c31930ca410012e4c</guid>
				<title>Bryan Xavier replied to the topic  &#034;Contingency Planning&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31471/</link>
				<pubDate>Wed, 30 Apr 2025 03:49:17 -0400</pubDate>

									<content:encoded><![CDATA[<p>One way of convincing management to invest in more contingency planning is to remind them that it is a regulatory and compliance risk. If the primary supplier cannot meet quality standards post its approval, that can cause major delays in&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/contingency-planning/#post-21618" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ffaabd87cfa68fd2e8c8cfb1ed860c4f</guid>
				<title>Bryan Xavier replied to the topic  &#034;The Manager’s Role in Sustaining Team Engagement During Trials&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31470/</link>
				<pubDate>Wed, 30 Apr 2025 03:13:31 -0400</pubDate>

									<content:encoded><![CDATA[<p>For long-running clinical trials, there are many ways to maintain engagement and motivation among team members. One way is to celebrate small milestones, like completing a trial phase. Showing appreciation for these small victories allows the team to more easily&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/the-managers-role-in-sustaining-team-engagement-during-trials/#post-21617" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0367a5eb04fb96e19c3ce69c4c4f639f</guid>
				<title>Bryan Xavier replied to the topic  &#034;Creating Realistic Schedules in Clinical Trials&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31381/</link>
				<pubDate>Wed, 23 Apr 2025 18:34:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>One obstacle that can complicate timeline planning for large scale clinical trials is the variability added by conducting trials across multiple countries. Global trials come with more complexity that can&#8217;t always be covered by traditional tools like Gantt Charts. Each&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/creating-realistic-schedules-in-clinical-trials/#post-21528" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">272ddb61b2cb133b40f7e7625685ffdc</guid>
				<title>Bryan Xavier replied to the topic  &#034;Dealing with Low Performers in Research Teams Without Losing Morale&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31380/</link>
				<pubDate>Wed, 23 Apr 2025 17:34:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>The first step should be to identify why the underperformance is happening, which can lead to visits to monitor process or talking to the team themselves to find the root cause. Then the necessary changes can be made to see&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/dealing-with-low-performers-in-research-teams-without-losing-morale/#post-21527" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">02dca3c480432a86bd991802cc0c26fd</guid>
				<title>Bryan Xavier replied to the topic  &#034;Keeping Clinical Research Teams Motivated During Long Timelines&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31379/</link>
				<pubDate>Wed, 23 Apr 2025 16:49:02 -0400</pubDate>

									<content:encoded><![CDATA[<p>One strategy that can be used for keeping clinical research teams motivated is to create and celebrate short-term wins. It was mentioned in this week&#8217;s slides that one motivator for people is team based praise, so breaking the project into&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-application-clinical-trial/keeping-clinical-research-teams-motivated-during-long-timelines/#post-21526" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ca92ce1c60a1433e9ca3f1895bee799a</guid>
				<title>Bryan Xavier replied to the topic  &#034;Cost Estimating – Choosing Between Speed and Accuracy&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31303/</link>
				<pubDate>Thu, 17 Apr 2025 04:36:53 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ms3548/' rel="nofollow ugc">@ms3548</a> I think the way to managing the transition from broad to bottom-up estimating is to treat it as a planned-hand off. For example, scheduling a formal review point once enough detail is available, like a completed WBS or when&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-knowledge-areas/cost-estimating-choosing-between-speed-and-accuracy/#post-21450" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0db10b36bb7e31093055007d465f2d08</guid>
				<title>Bryan Xavier replied to the topic  &#034;Scope Management and the Role of the WBS in Project Clarity&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31301/</link>
				<pubDate>Thu, 17 Apr 2025 04:26:51 -0400</pubDate>

									<content:encoded><![CDATA[<p>In addition to balancing detail and simplicity for the WBS, I think it&#8217;s also important the WBS structure has clear traceability between work and regulatory paperwork, like design inputs, outputs, verification and validation. If the WBS is too high-level, it&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-knowledge-areas/scope-management-and-the-role-of-the-wbs-in-project-clarity/#post-21448" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a3f2ac3e02de3d37221ecff48390e47f</guid>
				<title>Bryan Xavier replied to the topic  &#034;Allergan&#039;s BIOCELL Breast Implant Recall: A Case Study in Quality and Risk Management&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31300/</link>
				<pubDate>Thu, 17 Apr 2025 04:13:16 -0400</pubDate>

									<content:encoded><![CDATA[<p>I agree that regulatory approval shouldn&#8217;t be the end all be all for safety. There are multiple strategies that companies can and should take before a product hits the market. One such method is a Failure Modes and Effect Analysis,&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-knowledge-areas/allergans-biocell-breast-implant-recall-a-case-study-in-quality-and-risk-management/#post-21447" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">850d34a929b89a6dfadde0ce25ed0f0b</guid>
				<title>Bryan Xavier replied to the topic  &#034;What’s the Most Effective Form of Communication in Medical Device Projects?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31229/</link>
				<pubDate>Wed, 09 Apr 2025 01:09:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>In my experience, I&#8217;ve used weekly in person meetings in order to make actual progress in a project I&#8217;m working and discuss with coworkers. Then I use Slack and some of my free time in order to conduct more research&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/whats-the-most-effective-form-of-communication-in-medical-device-projects/#post-21376" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4d77a609a61c02048201f542f113bb18</guid>
				<title>Bryan Xavier replied to the topic  &#034;Impact of Testing Variability on Product Risk&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31228/</link>
				<pubDate>Wed, 09 Apr 2025 00:59:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>To build confidence in testing outcomes, companies often create a standardized test kit that includes the product sample, and instructions for handling, storage, and testing. This kit could include things like labeled materials, checklist for covering compound ratios, incubation time,&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/impact-of-testing-variability-on-product-risk/#post-21375" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4a607746a1c4aea71667e25cc901eaff</guid>
				<title>Bryan Xavier replied to the topic  &#034;Navigating the Risks of Post-Verification Changes&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31227/</link>
				<pubDate>Wed, 09 Apr 2025 00:04:56 -0400</pubDate>

									<content:encoded><![CDATA[<p>When facing a late-stage development issue, one method to consider is using the &#8220;5 Why&#8217;s&#8221; Method, where you&#8217;re keeping asking why the failure is happening up to 5 times to determine whether the root of the problem is due to&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/navigating-the-risks-of-post-verification-changes/#post-21374" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6fbd62b035966288f4f081fea733fcc1</guid>
				<title>Bryan Xavier posted a new topic  &#034;Managing Change Fatigue&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31140/</link>
				<pubDate>Wed, 26 Mar 2025 04:51:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>In complex and highly regulated projects like medical device development, changes are bound to happen. Design updates, documentation revision, and process adjustments are required to ensure compliance and quality, but when changes become frequent, teams can experience change fatigue. This&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/managing-change-fatigue/" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">28e53c039e2a9f419407d10273c53f15</guid>
				<title>Bryan Xavier replied to the topic  &#034;Importance of Lessons Learned in the Project Closing Phase&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/31139/</link>
				<pubDate>Wed, 26 Mar 2025 04:15:30 -0400</pubDate>

									<content:encoded><![CDATA[<p>As much as learning from mistakes is important for future projects, it should also be important to use the lessons learned in real-time for decision makings during the project, not just as something to review afterward. If certain patterns emerge&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/importance-of-lessons-learned-in-the-project-closing-phase/#post-21289" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>